Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Dr. Chapa’s OBGYN Clinical Pearls

ALERT: Methylene Blue- A Potential Cause of Serotonin Toxicity

07 Aug 2019

Description

Healthcare professionals and patients may not realize that methylene blue has monoamine oxidase inhibitor (MAOI) properties. Methylene blue should generally not be given to patients taking serotonergic drugs. When should patients stop taking SSRIs prior to methylene blue use? When should they be restarted? In this session, we will review the MOA of this common dye utilized in surgery and review ways to prevent a possible lethal reaction.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.